Status:
COMPLETED
How Effective Are Antithrombotic Therapies in Primary Percutaneous Coronary Intervention
Lead Sponsor:
Liverpool Heart and Chest Hospital NHS Foundation Trust
Conditions:
Acute ST Elevation Myocardial Infarction
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to compare unfractionated heparin (UFH) and bivalirudin in the performance and subsequent outcomes of Primary percutaneous coronary intervention. This will be a pragmatic ...
Detailed Description
HEAT-PPCI is a single-centre prospective, dual-arm, open-label, randomised controlled trial comparing two antithrombotic agents in patients undergoing PPCI. All patients presenting to the PPCI service...
Eligibility Criteria
Inclusion
- All patients presenting with a suspected myocardial infarction event with PPCI as the proposed index reperfusion strategy will be included in the trial
Exclusion
- ≤ 18 years of age
- Known intolerance, hypersensitivity or contraindication to any trial medication
- Active bleeding at presentation
- Artificial ventilation, reduced conscious level or other factors precluding the administration of oral antiplatelet therapy
- Previous enrolment in this trial
Key Trial Info
Start Date :
February 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
1829 Patients enrolled
Trial Details
Trial ID
NCT01519518
Start Date
February 1 2012
End Date
December 1 2013
Last Update
May 13 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Liverpool Heart and Chest Hospital
Liverpool, Merseyside, United Kingdom, L14 3PE